Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 161   

Articles published

MRK 60.00 -0.28 (-0.46%)
price chart
3 Reasons Merck & Co., Inc.'s Stock Could Fall
In other words, the stock market is a two-way street that allows stocks to move both up and down. So, as you read this bearish thesis on Merck keep in mind that just because the company has challenges to face, it doesn't necessarily mean the stock ...
Related articles »  
Merck Collaborates With Pfizer Again For Its PD-1 Immunotherapy
Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK) announced yesterday that they have partnered to conduct trials investigating the combined efficacy of the former's lung-cancer drug, Xalkori, along with the latter's experimental drug, Pembrolizumab ...
Pfizer to test Xalkori lung cancer drug with Merck immunotherapy  Reuters UK
RPT-UPDATE 2-Pfizer to test Xalkori lung cancer drug with Merck immunotherapy  Reuters
Related articles »  
Company Update: Merck & Co Inc (NYSE:MRK) � [video] Merck & Pfizer team up
Summary (NYSE:MRK) : Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.
Merck & Co. Now Covered by Analysts at Deutsche Bank (MRK)  Ticker Report
Related articles »  
Wednesday's Analyst Moves: Pfizer Inc., Merck & Co., Inc., Bristol-Myers ...
Deutsche Bank has initiated coverage on Eli Lilly and Co (LLY ) with a �Buy� rating and a $71 price target. This price target suggests an 11% increase from the stock's current price.
Pfizer Inc. (NYSE:PFE)'s Xalkori Move To Next Level With Collaboration ...  eMarketsDaily
Related articles »  
Merck & Co. Inc. (MRK) Among Biggest DJIA Losers on August 18
Shares of Merck & Co. Inc. led all laggers on the Dow Monday with a decline of 0.32%. The DJIA closed at 16,838.70, which is a 1.06% change from the previous day's close.
Related articles »  
Merck & Co. Inc. (MRK) Tops DJIA Gainers for August 22
The Dow closed at 17,001.20 on Friday, which is a -0.22% move from yesterday's close. Merck & Co. Inc. led all gainers with a 0.54% jump.
Merck & Co. Inc. (MRK) Among Biggest DJIA Losers on August 21
Shares of Merck & Co. Inc. led all laggers on the Dow Thursday with a decline of 1.06%. The DJIA closed at 17,039.60, which is a 0.36% change from the previous day's close.
Why Wall Street Is Not Bearish On Merck
None of the analysts covering Merck & Co., Inc. (MRK) are bearish due to the company's strong drug pipeline. However, many are not completely sure of Merck's future and have a neutral stance on the pharmaceutical.
3 Reasons Merck & Co., Inc.'s Stock Could Rise
You need to be willing to dig deeper and discover what the true growth drivers are for the company, which is exactly what we're going to do today.
Related articles »  
5 Things Merck & Co., Inc.'s Management Wants You to Know
In its second-quarter earnings results, released just two weeks ago, Merck reported a 1% decline in worldwide sales to $10.9 billion from the year-ago period, weighed-down by patent expirations and increasing competition, as its adjusted earnings per ...
Related articles »